002294:SHE
Shenzhen Salubris Pharmaceuticals Co Ltd
CNÂ¥30.07
arrow_downward
-3.13%(-0.97) 1D
Sep 11, 3:04:27 PM GMT+8 · CNY
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 002294...
Open
CNÂ¥30.80
High
CNÂ¥30.87
Low
CNÂ¥30.01
Mkt. cap
34.60B
Avg. vol.
20.07M
Volume
12.19M
Dividend
1.83%
Quarterly dividend
CNÂ¥0.14
Ex-dividend date
May 26, 2026
P/E ratio
49.77
52-wk high
CNÂ¥70.99
52-wk low
CNÂ¥29.25
EPS
CNÂ¥0.60
Shares outstanding
1.11B
No. of employees
4K
Open
CNÂ¥30.80
High
CNÂ¥30.87
Low
CNÂ¥30.01
Mkt. cap
34.60B
Avg. vol.
20.07M
Volume
12.19M
Dividend
1.83%
Quarterly dividend
CNÂ¥0.14
Ex-dividend date
May 26, 2026
P/E ratio
49.77
52-wk high
CNÂ¥70.99
52-wk low
CNÂ¥29.25
EPS
CNÂ¥0.60
Shares outstanding
1.11B
No. of employees
4K
News stories
From web sources and news partners
scanx.trade
·
1 day ago
Salubris Refiles HK IPO As Innovative Drug Share Hits 54.8%
Profile
Shenzhen Salubris Pharmaceuticals is a Chinese pharmaceutical company.
Founded in November 1998 and based in Shenzhen, it has a market cap of US$4.4 billion, 3,121 employees and annual sales of $553 million as of 2019.
Shenzhen Salubris is headed by the billionaire Ye Chenghai. Wikipedia
About Shenzhen Salubris Pharmaceuticals Co Ltd